An Australian Patent Opposition, Revocation and Extension of Term Round-Up from the Patent Office Journal dated 21 February 2013.
If you wish to oppose the grant of a patent, or if your grant own application has been opposed by third parties, please contact us.
Acceptance of the following patent applications has been opposed:
|2004210965||Altered FAD2 and FAD3 genes in brassica and the molecular marker-assisted detection thereof||Dow AgroSciences LLC||Pioneer Hi-Bred International, Inc|
|2007259122||Simultaneous, separate or sequential therapeutic use of at least one botulinum neurotoxin and of at least one opiate derivative||Ipsen Pharma S.A.S.||Allergan, Inc.|
|2009243527||Controlled release formulation||Euro-Celtique S.A.||Southern Cross Pharma Pty Ltd|
|2011201135||Wear assembly||ESCO Corporation||Ronneby Road Pty Ltd|
|2011201135||Wear assembly||ESCO Corporation||CQMS Pty Ltd|
Opposition to acceptance of the following applications has been withdrawn, and the application shall proceed to sealing:
|2003229403||Heap leaching||Technological Resources Pty Ltd||BHP Billiton SA Limited|
|2011200087||Deformable mechanical pipe coupling||Victaulic Company||Tyco Fire Products LP|
No additional opposition proceedings have been dismissed.
No additional applications have been withdrawn following opposition.
Extensions of Term of Standard Patents
No applications for Extension of Term under Section 70 have been made.
No additional application(s) for Extension of Term have been accepted under Section 74.
No applications for Extension of Term have been granted under Section 76.
Surrendered and Revoked Letters Patent
Surrendered Letters Patent
No patents have been offered for surrender.
Revocation of Letters Patent
No patents have been wholly or partially revoked in accordance with Section 137.